Associated tags: Contract research organization, TFS, CDS, Biotechnology, SRS, Pharmaceutical industry, Patient, Research, Hematology, Ophthalmology, Inflammation, Internal medicine, Neuroscience, Dermatology
Locations: SWEDEN, ISRAEL, MIDDLE EAST, EUROPE, PORTUGAL, UNITED STATES OF AMERICA, SPAIN
LUND, Sweden, March 12, 2024 /PRNewswire/ -- TFS HealthScience ( TFS ) , a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia.
Key Points:
- LUND, Sweden, March 12, 2024 /PRNewswire/ -- TFS HealthScience ( TFS ) , a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia.
- The APAC region presents a promising landscape for clinical research, with a diverse patient population encompassing various ethnicities, demographics, and medical conditions.
- TFS recognizes the potential to contribute significantly to advancing medical knowledge and improving patient outcomes in this vibrant and growing market.
- This strategic move not only broadens access to diverse patient populations and cutting-edge technologies but also leverages streamlined regulatory environments for faster, more efficient trial execution.
LUND, Sweden, March 11, 2024 /PRNewswire/ -- TFS HealthScience (TFS) , a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia.
Key Points:
- LUND, Sweden, March 11, 2024 /PRNewswire/ -- TFS HealthScience (TFS) , a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia.
- The APAC region presents a promising landscape for clinical research, with a diverse patient population encompassing various ethnicities, demographics, and medical conditions.
- TFS recognizes the potential to contribute significantly to advancing medical knowledge and improving patient outcomes in this vibrant and growing market.
- This strategic move not only broadens access to diverse patient populations and cutting-edge technologies but also leverages streamlined regulatory environments for faster, more efficient trial execution.
Retrieved on:
Tuesday, December 12, 2023
Health,
Technology,
Practice Management,
Managed Care,
General Health,
Clinical Trials,
Artificial Intelligence,
AI,
Research,
PAS,
RWD,
TFS,
Data analysis,
Partnership,
RWE,
Pharmaceutical industry Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS HealthScience are announcing a landmark collaboration to accelerate global clinical trials and research innovation, improve patient outcomes and reduce health disparities.
Key Points:
- Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS HealthScience are announcing a landmark collaboration to accelerate global clinical trials and research innovation, improve patient outcomes and reduce health disparities.
- The partnership will combine TFS’ capabilities, systems and clinical development expertise with PAS’ AI-enabled technology and comprehensive healthcare database .
- Eighty percent of all trials face premature termination or significant delays due to recruitment challenges – and marginalized populations, including Black and Hispanic individuals, remain historically underrepresented .
- By uniting their capabilities, PAS and TFS are committed to driving forward innovation in clinical research and offering efficient solutions that prioritize patient health outcomes and equity.
SRS,
Therapy,
Inflammation,
Internal medicine,
Research,
History,
Neuroscience,
Dermatology,
Patient,
TFS,
Ophthalmology,
Hematology,
Pharmaceutical industry,
Medical imaging LUND, Sweden, March 27, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand.
Key Points:
- LUND, Sweden, March 27, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand.
- TFS Portugal will increase the company's geographic footprint and expand its strategic resourcing capabilities across the Iberian Peninsula.
- Portugal has experienced two consecutive years of double-digit growth in company-sponsored clinical trials.
- "We are excited to grow our footprint in Europe with the opening of our office in Portugal," said TFS HealthScience CEO Bassem Saleh.
SRS,
Therapy,
Inflammation,
Internal medicine,
Research,
History,
Neuroscience,
Dermatology,
Patient,
TFS,
Ophthalmology,
Hematology,
Pharmaceutical industry,
Medical imaging LUND, Sweden, March 27, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand.
Key Points:
- LUND, Sweden, March 27, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand.
- TFS Portugal will increase the company's geographic footprint and expand its strategic resourcing capabilities across the Iberian Peninsula.
- Portugal has experienced two consecutive years of double-digit growth in company-sponsored clinical trials.
- "We are excited to grow our footprint in Europe with the opening of our office in Portugal," said TFS HealthScience CEO Bassem Saleh.
Inflammation,
Internal medicine,
Clinical trial,
GCP,
Research,
Neuroscience,
Dermatology,
TFS,
Ophthalmology,
Hematology,
Growth,
Entrepreneurship,
Pharmaceutical industry LUND, Sweden, March 20, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, announced its international expansion into Israel to enhance its offerings and geographic reach to support growing customer demand.
Key Points:
- LUND, Sweden, March 20, 2023 /PRNewswire/ -- Today, TFS HealthScience, a global contract research organization, announced its international expansion into Israel to enhance its offerings and geographic reach to support growing customer demand.
- The development includes a formalized agreement with the former external partner of TFS HealthScience in the Middle East, GCP Clinical Studies (GCP), Israel's leading contract research organization (CRO), and clinical research training center.
- "2023 continues to be a year of growth for the company as we announce our formal expansion into Israel," said Head of Clinical Development Solutions at TFS HealthScience, Luke Gill.
- "We are confident that this expansion will bring immense value to our clients and ultimately support the development of more lifesaving therapies."
Technology,
Clinical trials,
Software,
Networks,
Internet,
Health,
Data management,
Other Science,
Science,
Clinical trials,
Clinical data management,
Veeva Systems,
Clinical trial management system,
Vault,
Computer companies,
Computing,
Euthenics,
TFS HealthScience,
Veeva Systems Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.
Key Points:
- Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.
- "Veeva Vault Clinical Operations Suite gives us a foundation for further growth as we expand our service offerings globally," said Dr. Bassem Saleh, CEO, TFS HealthScience.
- Building on its success with Veeva Vault eTMF to maintain inspection readiness, the company will use Veeva Vault Study Startup to get studies up and running quickly, Veeva Vault CTMS to keep studies on track, and Veeva Vault Payments to simplify payments to global partner sites.
- "TFS HealthScience is transforming clinical operations to work more efficiently and better serve sponsors," said Pinar Benet, senior director strategy, Vault Clinical Operations at Veeva Systems.
Software,
Research,
General Health,
Networks,
Pharmaceutical,
Data management,
Technology,
Clinical trials,
Science,
Biotechnology,
Other Technology,
Health,
Other Science,
Clinical trials,
Clinical data management,
Veeva Systems,
Clinical trial management system,
Vault,
Computer companies,
Computing,
Euthenics,
TFS HealthScience,
Veeva Systems Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.
Key Points:
- Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform.
- "Veeva Vault Clinical Operations Suite gives us a foundation for further growth as we expand our service offerings globally," said Dr. Bassem Saleh, CEO, TFS HealthScience.
- Building on its success with Veeva Vault eTMF to maintain inspection readiness, the company will use Veeva Vault Study Startup to get studies up and running quickly, Veeva Vault CTMS to keep studies on track, and Veeva Vault Payments to simplify payments to global partner sites.
- "TFS HealthScience is transforming clinical operations to work more efficiently and better serve sponsors," said Pinar Benet, senior director strategy, Vault Clinical Operations at Veeva Systems.
